Menu Search
Equities

Centrum Medyczne Enel Med SA

ENE:WSE

Centrum Medyczne Enel Med SA

Actions
Health CareHealth Care Providers
  • Price (PLN)19.70
  • Today's Change0.20 / 1.03%
  • Shares traded638.00
  • 1 Year change+6.49%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Centrum Medyczne Enel-Med SA is a Poland-based company that provides medical services. The Company provides medical care for individuals or families, as well as medical care for entire companies. Among the Company’s services are specialist consultations, dental services, imaging diagnostics, rehabilitation, psychological centre, ophthalmological outpatient clinic, hypertensiology clinic, apnea diagnostics and treatment outpatient clinic, insomnia treatment clinic, sarcoidosis outpatient clinic, aesthetic medicine and others. Its centers are located in Warsaw, Poznan, Lodz and other Polish cities. The Company’s divisions and diagnostic laboratories are located in Warsaw, Lublin, Mielec and Poznan, among others. The Company's subsidiaries include Enel Invest Sp z o o and Enelbud Sp z o o.

  • Revenue in PLN (TTM)654.12m
  • Net income in PLN16.36m
  • Incorporated2007
  • Employees1.20k
  • Location
    Centrum Medyczne Enel Med SAul. Slominskiego 19 lok. 524WARSZAWA 00-195PolandPOL
  • Phone+48 224317701
  • Fax+48 224317703
  • Websitehttps://www.enel.pl/
More ▼

Institutional shareholders

22.66%Per cent of shares held by top holders
HolderShares% Held
Generali PTE SAas of 29 Dec 20234.67m16.51%
Allianz Polska PTE SAas of 29 Dec 20231.74m6.15%
PTE PZU SAas of 30 Jun 20230.000.00%
Data from 30 Jun 2023 - 29 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.